Issue 3/2012
Content (15 Articles)
Biopsy interpretation of colonic biopsies when inflammatory bowel disease is excluded
Tze S. Khor, Hiroshi Fujita, Koji Nagata, Michio Shimizu, Gregory Y. Lauwers
Combination of angiotensin II receptor blockers promotes proton pump inhibitor-based healing of reflux esophagitis
Hiroto Miwa, Michio Hongo, Motoyasu Kusano
The proximodistal aggravation of colitis depends on substance P released from TRPV1-expressing sensory neurons
Matthias A. Engel, Mohammad Khalil, Sonja M. Mueller-Tribbensee, Christoph Becker, Winfried L. Neuhuber, Markus F. Neurath, Peter W. Reeh
Preclinical study of the DNA repair inhibitor Dbait in combination with chemotherapy in colorectal cancer
Flavien Devun, Guilhem Bousquet, Julian Biau, Aurélie Herbette, Christophe Roulin, Frédérique Berger, Jian-Sheng Sun, Sylvie Robine, Marie Dutreix
A large-scale nationwide multicenter prospective observational study of triple therapy using rabeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in Japan
Toshio Fujioka, Nobuo Aoyama, Kyoko Sakai, Yoshiyuki Miwa, Mineo Kudo, Junichi Kawashima, Yasuo Matsubara, Jun Miwa, Koji Yakabi
Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan
Kazunari Tominaga, Ryuichi Iwakiri, Kazuma Fujimoto, Yasuhiro Fujiwara, Mio Tanaka, Yasuyuki Shimoyama, Eiji Umegaki, Kazuhide Higuchi, Motoyasu Kusano, Tetsuo Arakawa
Usefulness of differentiating metabolic syndrome into visceral fat type and subcutaneous fat type using ultrasonography in Japanese males
Masahiro Sogabe, Toshiya Okahisa, Shingo Hibino, Akira Yamanoi
Splenectomy enhances the anti-fibrotic effect of bone marrow cell infusion and improves liver function in cirrhotic mice and patients
Takuya Iwamoto, Shuji Terai, Yuko Mizunaga, Naoki Yamamoto, Kaoru Omori, Koichi Uchida, Takahiro Yamasaki, Yasuhiko Fujii, Hiroshi Nishina, Isao Sakaida
The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study
Yoshiyuki Narahara, Hidenori Kanazawa, Choitsu Sakamoto, Hitoshi Maruyama, Osamu Yokosuka, Satoshi Mochida, Masahito Uemura, Hiroshi Fukui, Yasukiyo Sumino, Yasushi Matsuzaki, Naohiko Masaki, Shigehiro Kokubu, Kiwamu Okita
Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine
Takeo Shimasaki, Yasuhito Ishigaki, Yuka Nakamura, Takanobu Takata, Naoki Nakaya, Hideo Nakajima, Itaru Sato, Xia Zhao, Ayako Kitano, Kazuyuki Kawakami, Takuji Tanaka, Tsutomu Takegami, Naohisa Tomosugi, Toshinari Minamoto, Yoshiharu Motoo
Reducing Peg-IFN doses causes later virologic response or no response in HCV genotype 1 patients treated with Peg-IFN alfa-2b plus ribavirin
Tsugiko Oze, Naoki Hiramatsu, Changho Song, Takayuki Yakushijin, Sadaharu Iio, Yoshinobu Doi, Masahide Oshita, Hideki Hagiwara, Eiji Mita, Toshifumi Ito, Yoshiaki Inui, Taizo Hijioka, Shinji Tamura, Harumasa Yoshihara, Atsuo Inoue, Yasuharu Imai, Eijiro Hayashi, Michio Kato, Masanori Miyazaki, Atsushi Hosui, Takuya Miyagi, Yuichi Yoshida, Tomohide Tatsumi, Shinichi Kiso, Tatsuya Kanto, Akinori Kasahara, Norio Hayashi, Tetsuo Takehara
Early evaluation of transcatheter arterial chemoembolization-refractory hepatocellular carcinoma
Kenya Yamanaka, Etsuro Hatano, Koji Kitamura, Taku Iida, Takamichi Ishii, Takahumi Machimito, Kojiro Taura, Kentaro Yasuchika, Hiroyoshi Isoda, Toshiya Shibata, Shinji Uemoto
Shall we use endoscopic submucosal dissection for every gastric neoplasia?
László Czakó, Viktória Terzin, Tibor Szalóki
Reply to the letter by L. Czakó et al. regarding “Endoscopic submucosal dissection as a treatment for gastric noninvasive neoplasia: a multicenter study by Osaka University ESD Study Group”
Motohiko Kato, Tsutomu Nishida, Tetsuo Takehara